Skip to main content
Log in

Increasing Frequency of Seborrheic Keratosis Diagnoses as a Favorable Consequence of Teledermatology-Based Skin Cancer Screening: A Cross-sectional Study of 34,553 Patients

  • short communication
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

An Erratum to this article was published on 09 May 2017

This article has been updated

Abstract

Background

Screening of skin cancer by teledermatology (TD) has improved the early detection of skin cancer by enhancing access to skin cancer clinics.

Objective

We sought to analyze how TD-based skin cancer screening has changed the frequency of consultations for benign lesions.

Patients and methods

A cross-sectional study including teleconsultations received during a 7-year period was conducted to analyze and compare the trendlines of each lesion type over the study period. Trendlines were analyzed using a linear regression model with the R-squared (R 2) test for goodness of fit.

Results

A total of 34,553 teleconsultations were included in the study. Seborrheic keratoses, followed by benign melanocytic lesions, were the most frequent lesions diagnosed. The pick-up rate for malignant lesions was 1:8.6 teleconsultations. Seborrheic keratoses and precancerous lesions showed a positive trendline with good fit to the linear model (R 2 = 0.8 and R 2 = 0.8, respectively). Tis-T1 malignant melanoma (in situ melanoma or melanoma with a Breslow thickness <1 mm) showed an increasing trendline with moderate-to-low fit to the model (R 2 = 0.4).

Conclusions

TD-based screening of skin cancer is associated with an increasing rate of consultations involving seborrheic keratoses, which can be considered a consequence of improved access to dermatologists resulting from TD implementation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Change history

  • 09 May 2017

    An erratum to this article has been published.

References

  1. Moreno-Ramírez D, Ferrándiz L. A 10-year history of teledermatology for skin cancer management. JAMA Dermatol. 2015;151:1289–90.

    Article  PubMed  Google Scholar 

  2. Ferrándiz L, Ruiz-de-Casas A, Martín-Gutiérrez FM, Peral-Rubio F, Méndez-Abda C, Ríos-Martín JJ, Moreno-Ramírez D. Effect of teledermatology on the prognosis of patients with cutaneous melanoma. Arch Dermatol. 2012;148:1025–8.

    Article  PubMed  Google Scholar 

  3. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kahn E, Sossong S, Goh A, Carpenter D, Goldstein S. Evaluation of skin cancer in Northern California Kaiser Permanente´s store-and-forward Teledermatology referral program. Telemed J E Health. 2013;19:780–5.

    Article  PubMed  Google Scholar 

  5. Warshaw EM, Gravely AA, Nelson DB. Reliability of store and forward Teledermatology for skin neoplasms. J Am Acad Dermatol. 2015;72:426–35.

    Article  PubMed  Google Scholar 

  6. Hansen C, Wilkinson D, Hansen M, Argenziano G. How good are skin cancer clinics at melanoma detection? Number needed to treat variability across a national clinic group in Australia. J Am AcadDermatol. 2009;61:599–604.

    Article  Google Scholar 

  7. Castillo-Arenas E, Garrido V, Serrano-Ortega S. Skin conditions in primary care: an analysis of referral demand. Actas Dermosifiliogr. 2014;105:271–5.

    Article  CAS  PubMed  Google Scholar 

  8. Ford JA, Pereira A. Does teledermatology reduces secondary care referrals and is it acceptable to patients and doctors? A service evaluation. J Eval Clin Pract. 2015;21:710–6.

    Article  PubMed  Google Scholar 

  9. Salerni G, Alonso C, Gorosito M, Ferández-Bussy R. Seborrheic keratosis-like melanoma. J Am Acad Dermatol. 2015;72(Suppl):S53–5.

    Article  PubMed  Google Scholar 

  10. Boyd AS, Su PF, Shyr Y, Tang YW. Squamous cell carcinomas in situ arising in seborrheic keratosis: an association with concomitant immunosuppression? Int J Dermatol. 2014;53:1346–50.

    Article  PubMed  Google Scholar 

  11. Marks R, Jolley D, McCormack, Dorevitch AP. Who removes pigmented skin lesions? J Am AcadDermatol. 1997;36:721–6.

    Article  CAS  Google Scholar 

  12. English DR, del Mar C, Burton RC. Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners. Med J Aust. 2004;180:16–9.

    PubMed  Google Scholar 

  13. Ahnlide I, Nielsen K, Bjellerup M. Diagnosis of pigmented skin tumours in a dermatological setting: different aspects of the number needed to excise as a measure of efficiency. Acta Derm Venereol. 2014;94:683–6.

    Article  PubMed  Google Scholar 

  14. Moreno-Ramírez D, Ojeda-Vila T, Ríos-Martín JJ, Ruiz-Villaverde R, de-Troya M, Sanz-Trelles A, Ferrándiz L, et al. The role of accessibility policies and other determinants of health care provision in the initial prognosis of malignant melanoma: a cross-sectional study. J Am Acad Dermatol. 2014;71:507–15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Moreno-Ramírez.

Ethics declarations

The local institutional review board has reviewed and approved this study.

Conflict of interest

The authors declare no conflict of interest.

Funding

This study has been partially funded by a competitive grant obtained from the Health Council of the Regional Government of Andalusia, Spain (PI0276-2013).

Additional information

An erratum to this article is available at https://doi.org/10.1007/s40257-017-0291-z.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moreno-Ramírez, D., Raya-Maldonado, J., Morales-Conde, M. et al. Increasing Frequency of Seborrheic Keratosis Diagnoses as a Favorable Consequence of Teledermatology-Based Skin Cancer Screening: A Cross-sectional Study of 34,553 Patients. Am J Clin Dermatol 18, 681–685 (2017). https://doi.org/10.1007/s40257-017-0283-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-017-0283-z

Keywords

Navigation